Senior insider sale
Chief Scientific Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$53.6K
67.69K shares
What this filing means
TAVERAS ARTHUR plans to sell 67.69K shares of X4 PHARMACEUTICALS, INC valued at approximately $53.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/1/2023ACC: 0001973141-23-000266
Officer· Chief Scientific Officer
Since Nov 2020
67.69K
Shares to sell
$53.6K
Approx. market value
67.69K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU
NA
11/1/2023
67.69KTotal acquired67.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/1/2023 | RSU NA | 67.69K | — |
| Total | 67.69K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
67.69K
Market value
$53.6K
11/1/2023
Total
Units
67.69K
Value
$53.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/1/2023 | 67.69K | $53.6K | Nasdaq | Planned |
| Total | 67.69K | $53.6K | ||